A. Nikolopoulou

发表

Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study.

J. Reubi, B. Nock, T. Maina, 2005, Journal of medicinal chemistry.

Radioimmunotherapy of Metastatic Prostate Cancer with ¹⁷⁷Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody.

S. Vallabhajosula, N. Bander, S. Tagawa, 2016, Current radiopharmaceuticals.

Noninvasive PK11195‐PET Image Analysis Techniques Can Detect Abnormal Cerebral Microglial Activation in Parkinson's Disease

Jenna M. Sullivan, P. Mozley, S. Vallabhajosula, 2018, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[11C]arachidonic acid incorporation measurement in human brain: Optimization for clinical use

P. Mozley, J. Mann, S. Rapoport, 2018, Synapse.

European Journal of Public Health Studies-ISSN 2668-1056

A. Nikolopoulou, Eirini Vogiatzaki, 2021 .

CCK-2/gastrin receptor-targeted tumor imaging with (99m)Tc-labeled minigastrin analogs.

M. Béhé, M. Gotthardt, T. Behr, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Folate hydrolase‐1 (FOLH1) is a novel target for antibody‐based brachytherapy in Merkel cell carcinoma

L. French, N. Bander, P. Nghiem, 2020, Skin health and disease.

Albumin-Binding PSMA Ligands: Implications for Expanding the Therapeutic Window

James M. Kelly, J. Babich, A. Nikolopoulou, 2018, The Journal of Nuclear Medicine.

Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-Resistant Prostate Cancer

S. Vallabhajosula, N. Bander, B. Robinson, 2013, Front. Oncol..

[99mTc]Demotate, a new 99mTc-based [Tyr3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results

G. Loudos, E. Chiotellis, B. Nock, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

Synthesis and sst2 binding profiles of new [Tyr3]octreotate analogs

B. Nock, T. Maina, A. Nikolopoulou, 2008, Journal of peptide science : an official publication of the European Peptide Society.

Dual-Target Binding Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer

James M. Kelly, D. S. Hage, J. Babich, 2017, The Journal of Nuclear Medicine.

[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging

G. Loudos, E. Chiotellis, J. Reubi, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

JHU-2545 Selectively Shields Salivary Glands and Kidneys during PSMA-Targeted Radiotherapy

C. Kratochwil, Marie-France Penet, D. Abou, 2018, bioRxiv.

A Single Dose of 225Ac-RPS-074 Induces a Complete Tumor Response in an LNCaP Xenograft Model

James M. Kelly, Justin J. Wilson, D. Schlyer, 2018, The Journal of Nuclear Medicine.

Trifunctional PSMA-targeting constructs for prostate cancer with unprecedented localization to LNCaP tumors

James M. Kelly, D. Schlyer, Yize Zhao, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

Phase I trial of docetaxel/prednisone plus fractionated dose radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody 177lu-J591 in patients with metastatic, castration-resistant prostate cancer (mCRPC).

H. Beltran, S. Vallabhajosula, N. Bander, 2014 .

Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs.

J. Reubi, Hanwen Zhang, B. Nock, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha Therapy.

James M. Kelly, Justin J. Wilson, P. Schaffer, 2017, Angewandte Chemie.

[18F]Fluoroethyltriazolyl Monocyclam Derivatives as Imaging Probes for the Chemokine Receptor CXCR4

James M. Kelly, M. Jin, J. Babich, 2019, Molecules.

Fluoroethyltriazolyl Monocyclam Derivatives as Imaging Probes for the Chemokine Receptor CXCR 4

James M. Kelly, M. Jin, J. Babich, 2019 .

Preclinical evaluation of a high affinity sarcophagine-containing PSMA ligand for 64Cu/67Cu-based theranostics in prostate cancer.

James M. Kelly, D. Schlyer, J. Babich, 2020, Molecular pharmaceutics.

[99mTc]Demotensin 5 and 6 in the NTS1-R-targeted imaging of tumours: synthesis and preclinical results

B. Nock, T. Maina, A. Nikolopoulou, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

Radioiodinated Capsids Facilitate In Vivo Non-Invasive Tracking of Adeno-Associated Gene Transfer Vectors

H. Voss, S. Vallabhajosula, D. Ballon, 2017, Scientific Reports.

Continuation of comprehensive quality control of the itG 68Ge/68Ga generator and production of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for clinical research studies.

James M. Kelly, S. Vallabhajosula, J. Babich, 2017, Nuclear medicine and biology.

Targeted Radionuclide Therapy of Prostate Cancer

S. Vallabhajosula, N. Bander, S. Tagawa, 2013 .

Radioimmunotherapy of Prostate Carcinoma

S. Vallabhajosula, N. Bander, S. Tagawa, 2013 .

Radioiodinated metaiodobenzylguanidine (MIBG): radiochemistry, biology, and pharmacology.

S. Vallabhajosula, A. Nikolopoulou, 2011, Seminars in nuclear medicine.

Synthesis and Evaluation of 11C-Labeled Triazolones as Probes for Imaging Fatty Acid Synthase Expression by Positron Emission Tomography

James M. Kelly, T. Jeitner, J. Babich, 2022, Molecules.

Bombesin Receptor Antagonists May Be Preferable to Agonists for Tumor Targeting

Anastasia Nikolopoulou, J. Reubi, B. Nock, 2008, Journal of Nuclear Medicine.

PACAP27 prevents Parkinson-like neuronal loss and motor deficits but not microglia activation induced by prostaglandin J2.

S. Vallabhajosula, A. Nikolopoulou, M. Figueiredo-Pereira, 2014, Biochimica et biophysica acta.

Parkinson-like neuronal loss and motor de fi cits but not microglia activation induced by prostaglandin J 2

S. Vallabhajosula, A. Nikolopoulou, M. Figueiredo-Pereira, 2014 .

Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets

P. Serrano, S. Vallabhajosula, J. Babich, 2018, Journal of Neuroinflammation.

Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets

S. Vallabhajosula, J. Babich, A. Nikolopoulou, 2018, Journal of Neuroinflammation.

Quantitative Whole-Body Imaging of I-124-labeled Adeno-Associated Viral Vector Biodistribution in Nonhuman Primates.

P. Mozley, D. Ballon, R. Crystal, 2020, Human gene therapy.

A Trifunctional Theranostic Ligand Targeting Fibroblast Activation Protein-α (FAPα)

James M. Kelly, T. Jeitner, J. Babich, 2021, Molecular Imaging and Biology.

Melodrama: The Cultural Emergence of a Genre

Michael L. Hays, A. Nikolopoulou, 1999 .

[18F]RPS-544: A PET tracer for imaging the chemokine receptor CXCR4.

James M. Kelly, M. Jin, J. Babich, 2018, Nuclear medicine and biology.

GnRH analogues containing conformationally restricted amino acids in positions 3 and 6: differential impact on pituitary binding affinity and direct antiproliferative effect on breast cancer cells†

B. Nock, T. Maina, A. Nikolopoulou, 2008 .

Assessment of PSMA targeting ligands bearing novel chelates with application to theranostics: Stability and complexation kinetics of 68Ga3+, 111In3+, 177Lu3+ and 225Ac3.

James M. Kelly, Shankar Vallabhajosula, Alejandro Amor-Coarasa, 2017, Nuclear medicine and biology.

Synthesis and pre-clinical evaluation of a new class of high-affinity 18F-labeled PSMA ligands for detection of prostate cancer by PET imaging

James M. Kelly, J. Babich, A. Nikolopoulou, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Quantitative SPECT imaging with Lu-177: A physical phantom evaluation

S. Vallabhajosula, J. Osborne, S. Goldsmith, 2012 .

99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients with Metastatic Prostate Cancer

S. Vallabhajosula, J. Osborne, S. Tagawa, 2014, The Journal of Nuclear Medicine.

Tetraamine‐modified octreotide and octreotate: labeling with 99mTc and preclinical comparison in AR4‐2J cells and AR4‐2J tumor‐bearing mice

B. Nock, T. Maina, A. Nikolopoulou, 2006, Journal of peptide science : an official publication of the European Peptide Society.

66Ga: A Novelty or a Valuable Preclinical Screening Tool for the Design of Targeted Radiopharmaceuticals?

James M. Kelly, J. Babich, A. Nikolopoulou, 2018, Molecules.

Toward stable N4-modified neurotensins for NTS1-receptor-targeted tumor imaging with 99mTc.

J. Reubi, D. Tourwé, B. Nock, 2006, Journal of Medicinal Chemistry.

New Gastrin Releasing Peptide Receptor-Directed [99mTc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation.

J. Reubi, G. Nicolas, B. Nock, 2018, Journal of medicinal chemistry.

2200 A PHASE 1 PILOT STUDY OF 99MTC-MIP-1404 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)/CT IMAGING IN MEN WITH PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY

S. Vallabhajosula, J. Osborne, B. Robinson, 2013 .

Population-based input function for TSPO quantification and kinetic modeling with [11C]-DPA-713

S. Nehmeh, P. Mozley, M. Akerele, 2021, EJNMMI Physics.

Tc-99m labeled small-molecule inhibitors of prostate-specific membrane antigen (PSMA): New molecular imaging probes to detect metastatic prostate adenocarcinoma (PC).

S. Vallabhajosula, J. Osborne, S. Tagawa, 2012, Journal of Clinical Oncology.

Otto: a 4.04 GBq (109 mCi) 68Ge/68Ga generator, first of its kind - extended quality control and performance evaluation in the clinical production of [68Ga]Ga-PSMA-11

J. Babich, A. Nikolopoulou, Nicole N. Waterhouse, 2020, EJNMMI Radiopharmacy and Chemistry.

PSMA targeted SPECT imaging biomarker to detect local and metastatic prostate cancer (PCa): Phase I studies with 99mTc-MIP-1404

S. Vallabhajosula, J. Osborne, S. Tagawa, 2013 .

Metastatic Prostate Cancer Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients with Tc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen : 99

S. Vallabhajosula, J. Osborne, S. Tagawa, 2014 .

Continuation of comprehensive quality control of the itG 68Ge/68Ga generator and production of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for clinical research studies.

James M. Kelly, S. Vallabhajosula, J. Babich, 2017, Nuclear medicine and biology.

Development of novel mixed-ligand oxotechnetium [SNS/S] complexes as potential 5-HT1A receptor imaging agents

E. Chiotellis, A. Terzis, C. Raptopoulou, 2001, JBIC Journal of Biological Inorganic Chemistry.

3D solution structure of [Tyr3]octreotate derivatives in DMSO: structure differentiation of peptide core due to chelate group attachment and biologically active conformation.

G. Spyroulias, B. Nock, T. Maina, 2005, Medicinal chemistry (Shariqah (United Arab Emirates)).